Skip to content

Cynosure RevLite SI

Save device

Q-Switched Tattoo/Pigment · QS Nd:YAG 532/1064 PTP

Technology: Nd:YAG Laser

Classification & configurations

Category group: Resurfacing & pigment (ablative, fractional, picosecond, vascular)

Current

At a glance

New price
$70k–$95kSource not documented
Used asking price
$20k–$35kSource not documented
FDA status
Supplies & recurring costs
See supply and replacement costs below.
View supply details
Sources and verified data on file

Data on file

Recurring consumables
Not verified
FDA
FDA ClearedK133254, K063112, K083899
Used asking prices
Not verified
  • This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
  • Bottle prices and estimates may still appear under Treatment & running costs.
  • The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.

Figures are reference points, not current offers. Used asking prices are not completed-sale values.

Read FDA-cleared indicationsExact wording from 3 FDA records

K133254 (Cynosure, Inc., 2014)

RevLite Q-Switched Nd:YAG Laser System. Intended Use: Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific indications: 1064 nm wavelength: • Tattoo Removal (dark ink: blue and black) • Dermal Pigmented Lesions; including, but not limited to: Nevus of Ota, Lentigines, Nevi, Melasma and Cafe-au-lait • Removal or lightening of hair with or without adjuvant preparation • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions; including, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength). 532 nm Wavelength (nominal delivered energy of 585 nm and 650 nm with the Optional Multilite Dye Laser Handpiece): • Tattoo removal (light ink: red, sky blue, green) • Vascular lesions including but not limited to: port wine birthmarks, telangiectasias, spider angioma, cherry angioma, spider nevi • Epidermal Pigmented lesions; including, but not limited to: cafe-au-lait birthmarks, solar lentigines, senile lentigines, Becker's nevi, Freckles, Nevus spilus, seborrheic keratosis • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions; including, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength)

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

K063112 (Hoya Conbio, Inc., 2006)

The RevLite Q-Switched Nd:YAG Laser System is indicated for Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific Indications: 1064 nm wavelength: Tattoo Removal: Dark Ink (Black & Blue); Nevus of Ota; Removal or lightening of unwanted hair with or without adjuvant preparation; Skin resurfacing procedures for the treatment of acne scars and wrinkles. 532 nm wavelength (nominal delivered energy of 585 nm and 650 nm with the Optional Multilite Dye Laser Handpiece): Tattoo Removal: Light Ink (Red, Sky Blue, Green); Treatment of Vascular Lesions including, but not limited to: port wine birthmarks, telangiectasias, spider angioma, cherry angioma, spider nevi; Treatment of Pigmented Lesions including, but not limited to: cafe-au-lait birthmarks, solar lentigines, senile lentigines, Becker's nevi, freckles, nevus spilus; Skin resurfacing procedures for the treatment of acne scars and wrinkles.

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

K083899 (Hoya Conbio, Inc., 2009)

Intended Use: Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific Indications: 1064 nm wavelength • Tattoo Removal (dark ink: blue and black) • Nevus of Ota • Removal or lightening of hair with or without adjuvant preparation • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions, such as, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength). 532 nm wavelength (nominal delivered energy of 585 nm and 650 nm with the Optional Multilite Dye Laser Handpiece) • Tattoo removal (light ink: red, sky blue, green) • Vascular lesions including but not limited to: port wine birthmarks, telangiectasias, spider angioma, cherry angioma, spider nevi • Epidermal Pigmented lesions including but not limited to: cafe-au-lait birthmarks, solar lentigines, senile lentigines, Becker's nevi, Freckles, Nevus spilus • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions, such as, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength).

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

Page updated: August 6, 2026 · How we verify

New and used price references
New$70k–$95k
Source not documented
Used$20k–$35k
Source not documented

Axis runs $0–$95k. Reference figures, not current offers. Used asking prices are not completed-sale values.

Consumable cost per treatment

Not verified

We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.

Price sourcesSources, dates and configurations
New: $70k–$95k·Researched estimate — no dated source on file yet; not a quote.
Used asking range: $20k–$35k·Researched estimate — no dated source on file yet; not a quote.
Key factsCompany, specifications and verification dates
Key facts
ManufacturerCynosure
CompanyOwner: Hahn & Company (South Korean private equity) (private equity owned, since 2024) · Distribution: direct
Parent companyCynosure Lutronic
Brand ownerCynosure
Built by (OEM)Cynosure LLC
CategoryQ-Switched Tattoo/Pigment
TechnologyQS Nd:YAG 532/1064 PTP
FDA statusFDA Cleared
510(k) citationK133254, K063112, K083899
New price range$70k–$95k
Used asking range$20k–$35k
ConsumablesNot published
Launch year2013
PricingNot published
Manufacturer-source documents checkedNot published

Overview

Still-current nanosecond standard

How it worksTechnology and manufacturing

How the technology works

Q-switched Nd:YAG delivers ~5-20 nanosecond pulses that shatter tattoo ink and melanin photoacoustically.

The SI's PhotoAcoustic Technology Pulse (PTP) mode splits energy into twin pulses ~100 microseconds apart, delivering up to ~60% more energy per shot with less epidermal heating — the basis of low-fluence laser toning for melasma in darker skin.

The flat-top homogenized beam avoids the hot spots that cause pinpoint bleeding and hypopigmentation on cheaper Q-switched lasers. Dye handpieces convert 532nm to 585nm (sky blue ink) and 650nm (green) for true multicolor work.

Patented technology

PTP dual-pulse delivery and the Smart Infinite (SI) flat-top precision optics are the ConBio-patented differentiators, along with the proprietary MultiLite dye-conversion handpiece system.

Origin

Fremont, California, USA (ConBio; acquired by HOYA, then Cynosure).

FDA & regulatory detailClearance timeline, authorization route and citation notes
Authorized via 510(k)

FDA-cleared indications (verbatim)

K133254 (Cynosure, Inc., 2014)

RevLite Q-Switched Nd:YAG Laser System. Intended Use: Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific indications: 1064 nm wavelength: • Tattoo Removal (dark ink: blue and black) • Dermal Pigmented Lesions; including, but not limited to: Nevus of Ota, Lentigines, Nevi, Melasma and Cafe-au-lait • Removal or lightening of hair with or without adjuvant preparation • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions; including, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength). 532 nm Wavelength (nominal delivered energy of 585 nm and 650 nm with the Optional Multilite Dye Laser Handpiece): • Tattoo removal (light ink: red, sky blue, green) • Vascular lesions including but not limited to: port wine birthmarks, telangiectasias, spider angioma, cherry angioma, spider nevi • Epidermal Pigmented lesions; including, but not limited to: cafe-au-lait birthmarks, solar lentigines, senile lentigines, Becker's nevi, Freckles, Nevus spilus, seborrheic keratosis • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions; including, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength)

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

K063112 (Hoya Conbio, Inc., 2006)

The RevLite Q-Switched Nd:YAG Laser System is indicated for Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific Indications: 1064 nm wavelength: Tattoo Removal: Dark Ink (Black & Blue); Nevus of Ota; Removal or lightening of unwanted hair with or without adjuvant preparation; Skin resurfacing procedures for the treatment of acne scars and wrinkles. 532 nm wavelength (nominal delivered energy of 585 nm and 650 nm with the Optional Multilite Dye Laser Handpiece): Tattoo Removal: Light Ink (Red, Sky Blue, Green); Treatment of Vascular Lesions including, but not limited to: port wine birthmarks, telangiectasias, spider angioma, cherry angioma, spider nevi; Treatment of Pigmented Lesions including, but not limited to: cafe-au-lait birthmarks, solar lentigines, senile lentigines, Becker's nevi, freckles, nevus spilus; Skin resurfacing procedures for the treatment of acne scars and wrinkles.

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

K083899 (Hoya Conbio, Inc., 2009)

Intended Use: Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific Indications: 1064 nm wavelength • Tattoo Removal (dark ink: blue and black) • Nevus of Ota • Removal or lightening of hair with or without adjuvant preparation • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions, such as, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength). 532 nm wavelength (nominal delivered energy of 585 nm and 650 nm with the Optional Multilite Dye Laser Handpiece) • Tattoo removal (light ink: red, sky blue, green) • Vascular lesions including but not limited to: port wine birthmarks, telangiectasias, spider angioma, cherry angioma, spider nevi • Epidermal Pigmented lesions including but not limited to: cafe-au-lait birthmarks, solar lentigines, senile lentigines, Becker's nevi, Freckles, Nevus spilus • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions, such as, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength).

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

Marketed for

Nd:YAG — QS Nd:YAG 532/1064 PTP

Marketing claims are the manufacturer's own and are not the same as a cleared indication.

510(k) numbers

K133254, K063112, K083899

Parent company: Cynosure Lutronic

Legal manufacturer: Cynosure LLC (United States)

Applicant on the FDA record

Cynosure, Inc.The applicant named on the FDA record can differ from the brand shown on the device.

Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.

Treatment & running costs

Treatments

Sessions & timing

No treatment schedule documented yet.

What practices charge

No sourced treatment price on file.

Supplies & recurring costs

Supply pricing is not documented with a dated source yet. Request an itemized supply quote.

Annual service & support

No annual service cost documented yet.

Payback calculatorModel your own volume, labor and service costs

Estimate your payback

Pre-filled from our published Cynosure RevLite SI data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.

Start from

No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.

Pre-filled from the midpoint of the published new-price range

20 is an illustrative default — change it to your volume.

No sourced per-session price on file — enter what you charge.

Required — enter your cost; missing data does not mean $0.

Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.

Annual service contract ÷ 12, if you carry one.

Your estimate

Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.

This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.

ComplianceScreening and contraindications on the manufacturer's record

Contraindications & screening

Gold-therapy history (chrysiasis — instant permanent darkening), isotretinoin within 6 months per conservative protocols, active infection/tanned skin at the site, cosmetic tattoos with iron/titanium oxides that can paradoxically darken.

PTP toning in melasma requires strict fluence discipline or you trade melasma for guttate hypopigmentation.

Warranty & serviceWhat to confirm in writing before you buy

Before buying new or used, confirm in writing:

  • Current warranty coverage
  • Included training
  • Service terms

Chains using this device

A chain listing does not establish availability at every location.

No confirmed chain deployments recorded yet.

Owner & operator reviews

Write a review

No owner or operator reviews yet. Be the first →

Current alternatives

Current catalog models to research. Confirm availability and configuration with the supplier.

Astanza Eternity

Q-Switched Tattoo/Pigment · $60k–$80k

Astanza Trinity

Q-Switched Tattoo/Pigment · $100k–$130k

Research comparisons

Includes current and older models.

History2 tracked changes

Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.

  1. August 5, 2026

    Warranty & service

    Source: Catalog update

  2. August 1, 2026

    Record created

    Added to The Aesthetic Index — August 2026

    Source: The Aesthetic Index editorial

Cite this data: The Aesthetic Index, "Cynosure RevLite SI — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).

Get the full State of Aesthetic Devices 2026 report

A catalog of US-marketed aesthetic and wellness devices — preview it free.

Get the report

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.